MedPath

Supported exercise training for men on androgen deprivation therapy (WP3)

Not Applicable
Suspended
Conditions
Prostate Cancer
Cancer
Registration Number
ISRCTN15691664
Lead Sponsor
Sheffield Teaching Hospitals NHS Foundation Trust
Brief Summary

2021 Results article in https://doi.org/10.1038/s41598-021-91876-y (added 10/09/2021)

Detailed Description

Not available

Recruitment & Eligibility

Status
Suspended
Sex
Male
Target Recruitment
45
Inclusion Criteria

1. Inclusion criteria for HCPs:
1.1 Involved in diagnosis and or treatment and or follow-up of men with prostate cancer on ADT
1.2 Able and willing to receive draft intervention training for HCPs as developed in STAMINA Work Package 2 (HRA approved: IRAS number 254343)
1.3 Based at a site with sufficient number of men started on long-term ADT to achieve recruitment target within timelines.

2. Inclusion criteria for men on ADT:
2.1 Prostate cancer within 12 months of starting ADT (at time of screening).
2.2 Receiving continuous ADT for a planned minimum of 12 months treatment
2.3 Willing and able to provide informed consent
2.4 Not due to receive chemotherapy within 3 months or those having completed chemotherapy

Exclusion Criteria

1. Exclusion criteria for HCPs:
1.1 Inability to read or speak English to an appropriate level

2. Exclusion criteria for participants:
2.1 Men with unstable angina
2.2 Uncontrolled hypertension and/ or diabetes mellitus
2.3 Recent myocardial infarction (within past 6 months)
2.4 Unable to provide informed consent (lack capacity)
2.5 Painful or unstable bony metastases
2.6 Fixed output pacemakers
2.7 Due to commence chemotherapy within 3 months

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcome in this context is not applicable. Data generated will be purely descriptive and are required to inform the refinement and optimisation of our complex intervention which will be evaluated during our subsequent planned multi-centre RCT.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath